Development for high-accuracy in vitro assay of vascular endothelial growth factor using nanomagnetically labeled immunoassay

C. C. Yang, K. W. Huang, S. Y. Yang*, H. H. Chen, T. C. Chen, C. S. Ho, S. F. Chang, J. J. Chieh, H. E. Horng, C. Y. Hong, H. C. Yang

*此作品的通信作者

研究成果: 雜誌貢獻期刊論文同行評審

8 引文 斯高帕斯(Scopus)

摘要

Nanomagnetically labeled immunoassays have been demonstrated to be promisingly applied in clinical diagnosis. In this work, by using antibody-functionalized magnetic nanoparticles and a high-temperature superconducting quantum interference device ac magnetosusceptometer, the assay properties for vascular endothelial growth factor (VEGF) in serum are investigated. By utilizing the assay method so-called immunomagnetic reduction, the properties of assaying VEGF are explored. In addition, the VEGF concentrations in serum samples of normal people and patients with either colorectal or hepatocellular cancer are detected. The experimental results show that the low-detection limit for assaying VEGF is 10 pg/mL, which is much lower than the clinical cut-off VEGF concentration of 50 pg/mL for diagnosing malignancy. Besides, there are no significant interference effects on assaying VEGF from hemoglobin, conjugated bilirubin, and triglyceride. The VEGF concentrations in serum samples donated by normal people and patients with hepatocellular carcinoma or colorectal cancer are detected. A clear difference in VEGF concentrations between these two groups is found. These results reveal the feasibility of applying nanomagnetically labeled immunoassay to clinics.

原文英語
文章編號695276
期刊Journal of Nanomaterials
2013
DOIs
出版狀態已發佈 - 2013
對外發佈

ASJC Scopus subject areas

  • 材料科學(全部)

指紋

深入研究「Development for high-accuracy in vitro assay of vascular endothelial growth factor using nanomagnetically labeled immunoassay」主題。共同形成了獨特的指紋。

引用此